IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis
about
Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17AThe biological functions of T helper 17 cell effector cytokines in inflammationAnti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunityUlcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association studyTumor-specific Th17-polarized cells eradicate large established melanomaInterleukin-22 ameliorates acute severe pancreatitis-associated lung injury in miceGut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infectionCytokine-Induced Modulation of Colorectal CancerInterleukin-22 in Graft-Versus-Host Disease after Allogeneic Stem Cell TransplantationIntegrating Immunologic Signaling Networks: The JAK/STAT Pathway in Colitis and Colitis-Associated CancerMechanisms of interleukin-22's beneficial effects in acute pancreatitisInterleukin-22 Signaling in the Regulation of Intestinal Health and DiseaseTherapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel DiseaseTh17 plasticity and its changes associated with inflammatory bowel diseaseGoblet cells and mucins: role in innate defense in enteric infectionsReview: The interleukin-23/interleukin-17 axis in spondyloarthritis pathogenesis: Th17 and beyondRole of group 3 innate lymphoid cells in antibody productionIL-22 Restrains Tapeworm-Mediated Protection against Experimental Colitis via Regulation of IL-25 ExpressionLoss of Function of Intestinal IL-17 and IL-22 Producing Cells Contributes to Inflammation and Viral Persistence in SIV-Infected Rhesus MacaquesOverview of cytokines and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel diseasesDysregulation of Group 3 Innate Lymphoid Cells in the Pathogenesis of Inflammatory Bowel DiseaseEctopic Tertiary Lymphoid Tissue in Inflammatory Bowel Disease: Protective or Provocateur?Cytokines, IBD, and colitis-associated cancerHelminthic therapy: improving mucosal barrier functionA human natural killer cell subset provides an innate source of IL-22 for mucosal immunityIL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestineIdentification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosisDexamethasone suppresses interleukin-22 associated with bacterial infection in vitro and in vivoPeptidoglycan recognition proteins protect mice from experimental colitis by promoting normal gut flora and preventing induction of interferon-gammaHVEM signalling at mucosal barriers provides host defence against pathogenic bacteriaHigh fat diet induces formation of spontaneous liposarcoma in mouse adipose tissue with overexpression of interleukin 22IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancerInflammatory bowel diseaseInflammatory bowel diseaseIL-22 deficiency alters colonic microbiota to be transmissible and colitogenic.Epithelial IL-23R Signaling Licenses Protective IL-22 Responses in Intestinal InflammationIn vivo dioxin favors interleukin-22 production by human CD4+ T cells in an aryl hydrocarbon receptor (AhR)-dependent manner.Interactions between the host innate immune system and microbes in inflammatory bowel disease.Chitinase 3-like 1 synergistically activates IL6-mediated STAT3 phosphorylation in intestinal epithelial cells in murine models of infectious colitis.Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17.
P2860
Q24597173-2588E769-B120-4C0F-AD4B-63AD8B842CE8Q24614431-2880BD7D-CF95-4EED-8E5F-07062BA07F6BQ24642507-30658C12-5BEB-40FF-B787-BFA0ECC5419EQ24643514-E9EB1E52-0AA9-47D7-9BDE-9B59DD8D1F83Q24648032-176CB1EF-5299-4E3C-A30E-6E7BC39076E6Q24658609-7C4D1745-7A6D-4E36-A24C-A479C8E276B3Q26748743-2C9D5339-0962-4446-B19B-DA6E0587CDD8Q26752374-668702B7-4BEF-4812-8F24-B20DE94D1843Q26752528-47CA8EDD-791F-4E64-847C-4B64F1954966Q26764757-65898AFE-C2E9-453F-A88F-F78E0F5CCB73Q26766654-03EC7010-02BE-440C-B779-2B7582092BC5Q26770224-DAC4E44C-7A34-4F0E-8C63-508F43878BABQ26771122-D2026F74-3F98-47B3-B70B-73D6325A9180Q26775934-CDB2A7E2-DE8A-400B-B2EC-4810EC8C4D1AQ26822449-B0448F90-C43D-47E8-B762-127A2FA190F4Q26991709-1188C4AF-DF66-46E7-A4EC-38C3275E7979Q27001687-537652DB-F112-4B86-A260-A2242A4C0190Q27315163-FBA1280C-B5B7-42FF-ABB0-ABFDA7531523Q27316093-0ECA1E83-E81A-45A5-A735-B05616119489Q28069372-E69AB3C7-8B69-4003-8931-B70C36AC185FQ28075218-0C3ED45C-434F-4074-9EF9-C959BD4FC074Q28077990-F044F63F-1277-408D-9AE9-5871761111AAQ28080901-988472B9-FE9E-4EEC-B365-ED46EB24398EQ28263272-3DE5C27B-6596-421E-8AD3-BC703396D0CEQ28299539-BA1C5A81-A88B-4DAE-873B-D8DDBFD047DBQ28506198-28AA94C1-D8B2-4280-BA07-E8056822DFD5Q28533202-E7D431F0-C5C5-42A9-A808-A99E5C2780C0Q28573335-2EFA2BFA-9185-426A-8152-ED289F68731EQ28587904-EC6707F5-A3A5-4F9A-BFD2-A1DA4A901039Q28590892-F65AFB30-7EDA-4C54-B37B-11DAE6E1B1B1Q28740922-83ADD200-C3D8-41B8-AF69-A8A63CB26960Q29614594-65C0E25F-0E2C-4E1D-99B4-34087A196839Q29615500-4827E3E0-6035-48E9-85B1-F73B220BEEBDQ29616286-38FDC3AC-4A28-4261-9DE3-B3D22AC0C844Q30539616-B35FCCC6-AE49-4402-AFA2-AD955E51C8BCQ30853216-31881CCA-1453-4744-B6E9-427B202269D0Q31007679-8A4310F7-8EFD-454A-9EF6-08DFDE1671E3Q33554402-DE30C0F2-D41B-483A-B62F-690CA8FE8ACDQ33576348-4B1D41FE-34A7-44AD-B2F4-57A8E868DC39Q33590409-AD4ABCAF-121C-40CC-9013-593D0A654E0E
P2860
IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis
@ast
IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis
@en
type
label
IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis
@ast
IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis
@en
prefLabel
IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis
@ast
IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis
@en
P2093
P2860
P356
P1476
IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis
@en
P2093
Akira Andoh
Atsuhiro Ogawa
Atsushi Mizoguchi
Atul K Bhan
Emiko Mizoguchi
Ken Sugimoto
Ramnik J Xavier
Richard S Blumberg
Yasuyo Shimomura
P2860
P304
P356
10.1172/JCI33194
P407
P577
2008-02-01T00:00:00Z